The latest meta-analyses of Jiang et al. [27] revealed a protective role of the HLA-G 14 bp ins/ins genotype compared to the HLA-G 14 bp del/del genotype (OR = 0.65, p < 0.05) in breast cancer patients. Here, HLA-G is linked to breast carcinoma.